NCT06570031 2026-06-05ONO-4578-06:Phase I Study of ONO-4578 and Letrozole Plus CDK4 /6 Inhibitors in Breast CancerOno Pharmaceutical Co., Ltd.Phase 1 Completed46 enrolled